ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR

Approximately 3–7% of non-small cell lung cancers harbor an anaplastic lymphoma kinase (ALK) gene fusion, constituting a new molecular subtype of lung cancer that responds to crizotinib, an ALK inhibitor. Although previous studies have evaluated ALK-rearranged lung cancers, the comprehensive analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Pan, Yunjian, Wang, Rui, Sun, Yihua, Hu, Haichuan, Shen, Xuxia, Lu, Yongming, Shen, Lei, Zhu, Xiongzeng, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724879/
https://www.ncbi.nlm.nih.gov/pubmed/23922677
http://dx.doi.org/10.1371/journal.pone.0069016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724879/
https://www.ncbi.nlm.nih.gov/pubmed/23922677
http://dx.doi.org/10.1371/journal.pone.0069016

Ejemplares similares